Olgu Sunumu
BibTex RIS Kaynak Göster

Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Yıl 2022, Cilt: 2 Sayı: 2, 1 - 5, 01.08.2022

Öz

Aim: The retrospective evaluation of abdominal vasculitis detected by FDG PET/CT examinations.
Materials and Methods: Seven patients (3 Female, 4 Male, 26-72 years old) were subjects of this study. The images of the patients as well as clinic and pathologic features were analyzed retrospectively.
Results: The determination of the abdominal vasculitis is possible as a primary diagnosis or incidentally during an investigation of a known another disease (malignancy).
Conclusion: This case series demonstrates the significance of this clinical entity as well as the associated malignancy with this disease by FDG PET/CT.

Kaynakça

  • 1. Galli, E., Muratore, F., Mancuso, P., Boiardi, L., Marvisi, C., Besutti, G., Spaggiari, L., Casali, M., Versari, A., Giorgi Rossi, P., & Salvarani, C. (2022). The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford, England), keac125. Advance online publication. https://doi.org/10.1093/rheumatology/keac125
  • 2. Chen, Z., Zhao, Y., Wang, Q., Li, Y., Li, H., & Zhou, Y. (2022). Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis. Clinical rheumatology, 41(5), 1499–1509. https://doi.org/10.1007/s10067-021-06039-1
  • 3. Bonnefoy PB, Goutte J, Jacquet-Francillon N, Habouzit V, Prevot N. Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT. Clin Nucl Med. 2021 Apr 1;46(4):e218-e220
  • 4. Wu, S., Pang, Y., Zhao, L., Zhao, L., & Chen, H. (2021). 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis. Clinical nuclear medicine, 46(10), 847–849. https://doi.org/10.1097/RLU.0000000000003692
  • 5. Espitia, O., Blonz, G., Urbanski, G., Landron, C., Connault, J., Lavigne, C., Roblot, P., Maillot, F., Audemard-Verger, A., Artifoni, M., Durant, C., Guyomarch, B., Hamidou, M., Magnant, J., Agard, C., & French Study Group for Large Vessel Vasculitis (GEFA) (2021). Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event. Arthritis research & therapy, 23(1), 14. https://doi.org/10.1186/s13075-020-02396-5
  • 6. Mestre-Torres, J., Martínez-Valle, F., Gabaldón, A., Simó-Perdigó, M., Salcedo-Allende, M. T., Navales-Mateu, I., & Solans-Laqué, R. (2022). Are Temporal Artery Biopsy Findings Related to PET/CT Findings in Giant Cell Arteritis?. Clinical nuclear medicine, 47(5), 387–393. https://doi.org/10.1097/RLU.0000000000004097
  • 7. Galli, E., Muratore, F., Mancuso, P., Boiardi, L., Marvisi, C., Besutti, G., Spaggiari, L., Casali, M., Versari, A., Giorgi Rossi, P., & Salvarani, C. (2022). The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford, England), keac125. Advance online publication. https://doi.org/10.1093/rheumatology/keac125
  • 8. Duff L, Scarsbrook AF, Mackie SL, Frood R, Bailey M, Morgan AW, Tsoumpas C. A methodological framework for AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET-CT images: Initial analysis. J Nucl Cardiol. 2022 Mar 23. doi: 10.1007/s12350-022-02927-4
  • 9. Martínez-Rodríguez, I., Jiménez-Alonso, M., Quirce, R., Jiménez-Bonilla, J., Martínez-Amador, N., De Arcocha-Torres, M., Loricera, J., Blanco, R., González-Gay, M. Á., & Banzo, I. (2018). 18F-FDG PET/CT in the follow-up of large-vessel vasculitis: A study of 37 consecutive patients. Seminars in arthritis and rheumatism, 47(4), 530–537. https://doi.org/10.1016/j.semarthrit.2017.08.009
  • 10. Sangolli, P. M., & Lakshmi, D. V. (2019). Vasculitis: A Checklist to Approach and Treatment Update for Dermatologists. Indian dermatology online journal, 10(6), 617–626. https://doi.org/10.4103/idoj.IDOJ_248_18.
Yıl 2022, Cilt: 2 Sayı: 2, 1 - 5, 01.08.2022

Öz

Kaynakça

  • 1. Galli, E., Muratore, F., Mancuso, P., Boiardi, L., Marvisi, C., Besutti, G., Spaggiari, L., Casali, M., Versari, A., Giorgi Rossi, P., & Salvarani, C. (2022). The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford, England), keac125. Advance online publication. https://doi.org/10.1093/rheumatology/keac125
  • 2. Chen, Z., Zhao, Y., Wang, Q., Li, Y., Li, H., & Zhou, Y. (2022). Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis. Clinical rheumatology, 41(5), 1499–1509. https://doi.org/10.1007/s10067-021-06039-1
  • 3. Bonnefoy PB, Goutte J, Jacquet-Francillon N, Habouzit V, Prevot N. Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT. Clin Nucl Med. 2021 Apr 1;46(4):e218-e220
  • 4. Wu, S., Pang, Y., Zhao, L., Zhao, L., & Chen, H. (2021). 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis. Clinical nuclear medicine, 46(10), 847–849. https://doi.org/10.1097/RLU.0000000000003692
  • 5. Espitia, O., Blonz, G., Urbanski, G., Landron, C., Connault, J., Lavigne, C., Roblot, P., Maillot, F., Audemard-Verger, A., Artifoni, M., Durant, C., Guyomarch, B., Hamidou, M., Magnant, J., Agard, C., & French Study Group for Large Vessel Vasculitis (GEFA) (2021). Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event. Arthritis research & therapy, 23(1), 14. https://doi.org/10.1186/s13075-020-02396-5
  • 6. Mestre-Torres, J., Martínez-Valle, F., Gabaldón, A., Simó-Perdigó, M., Salcedo-Allende, M. T., Navales-Mateu, I., & Solans-Laqué, R. (2022). Are Temporal Artery Biopsy Findings Related to PET/CT Findings in Giant Cell Arteritis?. Clinical nuclear medicine, 47(5), 387–393. https://doi.org/10.1097/RLU.0000000000004097
  • 7. Galli, E., Muratore, F., Mancuso, P., Boiardi, L., Marvisi, C., Besutti, G., Spaggiari, L., Casali, M., Versari, A., Giorgi Rossi, P., & Salvarani, C. (2022). The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford, England), keac125. Advance online publication. https://doi.org/10.1093/rheumatology/keac125
  • 8. Duff L, Scarsbrook AF, Mackie SL, Frood R, Bailey M, Morgan AW, Tsoumpas C. A methodological framework for AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET-CT images: Initial analysis. J Nucl Cardiol. 2022 Mar 23. doi: 10.1007/s12350-022-02927-4
  • 9. Martínez-Rodríguez, I., Jiménez-Alonso, M., Quirce, R., Jiménez-Bonilla, J., Martínez-Amador, N., De Arcocha-Torres, M., Loricera, J., Blanco, R., González-Gay, M. Á., & Banzo, I. (2018). 18F-FDG PET/CT in the follow-up of large-vessel vasculitis: A study of 37 consecutive patients. Seminars in arthritis and rheumatism, 47(4), 530–537. https://doi.org/10.1016/j.semarthrit.2017.08.009
  • 10. Sangolli, P. M., & Lakshmi, D. V. (2019). Vasculitis: A Checklist to Approach and Treatment Update for Dermatologists. Indian dermatology online journal, 10(6), 617–626. https://doi.org/10.4103/idoj.IDOJ_248_18.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Onkoloji ve Karsinogenez
Bölüm Case Reports
Yazarlar

Zehra Pınar Koç Bu kişi benim 0000-0002-3274-5790

Pınar Pelin Özcan Bu kişi benim 0000-0003-0147-2678

Nurdan Oruçoğlu Bu kişi benim 0000-0002-8613-5373

Hamide Sayar Bu kişi benim 0000-0002-8273-2605

Yayımlanma Tarihi 1 Ağustos 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 2 Sayı: 2

Kaynak Göster

APA Koç, Z. P., Özcan, P. P., Oruçoğlu, N., Sayar, H. (2022). Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging, 2(2), 1-5.
AMA Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. Ağustos 2022;2(2):1-5.
Chicago Koç, Zehra Pınar, Pınar Pelin Özcan, Nurdan Oruçoğlu, ve Hamide Sayar. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 2, sy. 2 (Ağustos 2022): 1-5.
EndNote Koç ZP, Özcan PP, Oruçoğlu N, Sayar H (01 Ağustos 2022) Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging 2 2 1–5.
IEEE Z. P. Koç, P. P. Özcan, N. Oruçoğlu, ve H. Sayar, “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”, Molecular Oncologic Imaging, c. 2, sy. 2, ss. 1–5, 2022.
ISNAD Koç, Zehra Pınar vd. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging 2/2 (Ağustos 2022), 1-5.
JAMA Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2022;2:1–5.
MLA Koç, Zehra Pınar vd. “Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”. Molecular Oncologic Imaging, c. 2, sy. 2, 2022, ss. 1-5.
Vancouver Koç ZP, Özcan PP, Oruçoğlu N, Sayar H. Abdominal Vasculitis Determined by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2022;2(2):1-5.